US Stock MarketDetailed Quotes
ELTP ELITE PHARMACEUTICALS INC
- 0.149
- +0.006+4.00%
15min DelayTrading May 20 11:34 ET
151.36MMarket Cap7.83P/E (TTM)
0.150High0.145Low602.81KVolume0.149Open0.143Pre Close88.52KTurnover0.08%Turnover Ratio37.18P/E (Static)1.02BShares0.21052wk High3.23P/B117.69MFloat Cap0.09352wk Low--Dividend TTM791.36MShs Float0.210Historical High--Div YieldTTM3.50%Amplitude0.093Historical Low0.146Avg Price1Lot Size
About ELITE PHARMACEUTICALS INC Company
Elite Pharmaceuticals, Inc. engages in the development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) segments. The ANDA segment includes generic pharmaceuticals. The NDA segment is composed of branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.
Company Profile
SymbolELTP
Company NameELITE PHARMACEUTICALS INC
Founded1997
MarketPink Market
Employees53
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
Address165 Ludlow Avenue
CityNorthvale
ProvinceNew Jersey
CountryUnited States of America
Zip Code07647
Phone1-201-750-2646
Websitehttp://www.elitepharma.com
Company Executives
- Name
- Position
- Salary
- Nasrat Hakim
- President, Chief Executive Officer and Director
- --
- Carter J. Ward
- Chief Financial Officer, Secretary and Treasurer
- --
- Douglas Plassche
- Executive Vice President of Operations
- --
- Barry Dash, Ph. D
- Director
- --
- Jeffrey Whitnell
- Director
- --
- Davis Caskey
- Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg